Zura Bio Limited (ZURA)
Last updated: 2026-10-24 04:04:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Zura Bio Limited (ZURA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $3.36, with a market capitalization of $395.77M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.25 to $7.44. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$395.77M | |
$3.36 | |
$37.55 | |
$0.97 | |
$3.53 | |
79.56K | |
2.35M | |
-- | |
$7.44 | |
$3.25 | |
-- | |
-- |
Zura Bio Limited (ZURA) Latest Closing Stock Price
Zura Bio Limited (ZURA) last closed at $3.53 as of 2026-10-23 23:56:00, unchanged from the previous close of $3.53.
During the latest regular trading session, ZURA traded between $0.97 and $37.55, with a volume of 79.56K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Zura Bio Limited (ZURA) 7-Day Stock Price Change
Over the past seven days, Zura Bio Limited (ZURA) moved from $4.41 to $3.36, representing a decline of 23.92% ($1.06).
The stock traded between $3.36 and $4.62 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 5.22 million shares, down versus the previous seven-day period, indicating lower trading activity.
ZURA 52-Week Price Position
Position in Range: 2.5%
ZURA is currently trading at $3.36, placing it 2.5% of the way from its 52-week low of $3.25 to its 52-week high of $7.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Zura Bio Limited (ZURA)?
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
Zura Bio Limited Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 40 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Zura Bio Limited (ZURA) Stock on MEXC
Eligible investors can buy real shares of Zura Bio Limited (ZURA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Zura Bio Limited (ZURA) stock price today?
2.Is ZURA stock going up or down today?
3.What is ZURA pre-market price?
4.What is ZURA after-hours price?
5.Is ZURA stock trading now?
6.Where does ZURA sit relative to its 52-week high and low?
7.What sector is Zura Bio Limited in?
8.What is Zura Bio Limited's market capitalization and where is it listed?
9.How is ZURA valued in terms of P/E ratio and EPS?
10.Does Zura Bio Limited pay a dividend?
Explore More US Stocks
Search Stocks
ZURA Stock Calculator
Estimate the value between ZURA shares and USD.
ZURA Shares to USD
1.00 ZURA shares = 3.355 USD
Calculations are estimates based on the latest available price and are for reference only.


